Company

stormtherapeutics

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

STORM Therapeutics is a clinical-stage biotechnology company pioneering cellular reprogramming through RNA modifications to treat disease.

Also known as STORM Therapeutics, STORM Therapeutics Limited

Biotech & therapeutics
Care delivery & digital health
Health IT

Status: Operatingas of 2026-09-17
Business model: B2B
Legal name: STORM Therapeutics Limited

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Its world leading understanding of RNA modifying enzymes (RME) has led to the discovery of breakthrough small molecule drugs that precisely reprogram cells through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases.

Funding snapshot

Total raised: $56MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round: Series C, $56M2026-04-16

Funding rounds

Series C: $56M2026-04-16, Company stated

Products

Other: STC-15
Web: STC-15

Relationships

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.